Skip to main content
. 2012 Jun 14;7(3):286–295. doi: 10.1111/j.1750-2659.2012.00388.x

Table 4.

Parameter estimates obtained for season 2000–2001 under different assumptions for vaccine efficacy (VE) or generation time (GT), or under model variants

Model variant AIC R 2 Transmissibility θ Susceptible fraction S 0 Reporting rate ρ (%) RE
Baseline 549·4 C 0·99 
A 0·90 
E 0·26 
Tot 0·97 C 0·375 
A–E 0·179 
 C 1·0 
A 0·775 
E 0·275 
 19·7 1·36
VE = 50% 556·9 C 0·99 
A 0·90 
E 0·21 
Tot 0·97 C 0·375 
A–E 0·178 
 C 1·0 
A 0·777 
E 0·304 
 19·8 1·36
GT = 2·6 days 546·7 C 0·99 
A 0·92 
E 0·28 
Tot 0·97 C 0·449 
A–E 0·223 
 C 1·0 
A 0·772 
E 0·272 
 21·7 1·31
GT = 4 days 558·2 C 0·99 
A 0·85 
E 0 
Tot 0·96 C 0·277 
A–E 0·118 
 C 1·0 
A 0·786 
E 0·282 
 16·7 1·50
θC = θA = θE 722·9 C 0·98 
A 0·58 
E 0 
Tot 0·89 0·335 C 1·0 
A 0·545 
E 0·243 
 22·0 1·32
θC ≠ θA ≠ θE 548·2 C 0·99 
A 0·90 
E 0·33 
Tot 0·97 C 0·376 
A 0·181 
E 0·089 
 C 1·0 
A 0·772 
E 0·309 
 19·6 1·37
θC = θA = θE
ρC ≠ ρA ≠ ρE 556·3 C 0·99 
A 0·96 
E 0·41 
Tot 0·99 0·284 C 1·0 
A 0·837 
E 0·351 
 C 20·3 
A 5·9 
E 2·9 
 1·35